Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Multipotent Stem Cell Regenerative Medicine Technology (Guangzhou) Co., Ltd. is a biotechnology company based in Guangzhou, China, specializing in the research, development, and application of human cell technologies. Established in 2018 as a subsidiary of the New Life Group, the company operates research laboratories at the Guangdong Pharmaceutical University Science Park. Its core business includes the storage of stem cells and immune cells, the development of regenerative medicine solutions, and the production of stem cell-derived medical beauty and anti-aging products. With a portfolio of over 20 patents, the company provides technical services for clinical medical applications and is recognized as a high-tech enterprise in the Guangdong region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Multipotent stem cell regenerative medicine technology.